UPDATED Mar 24, 2024
Get exposure to an age-old industry - tobacco.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
PG * | US$2,715.00 | 0.3% | 0.5% | US$380.4b | US$2,838.09 | PE26.3x | E7.2% | 2.3% | ||
OR N | €8,317.24 | 0% | 3.4% | €231.3b | €8,441.62 | PE37.4x | E7.5% | 1.5% | ||
UL N | UK£831.92 | 0% | -9.7% | UK£99.5b | UK£876.56 | PE17.9x | E4.4% | 3.7% | ||
ULVR N | UK£871.08 | 0% | n/a | UK£98.4b | UK£972.92 | PE13.7x | E-1.3% | 3.7% | ||
CL * | US$1,485.03 | 0.3% | 10.9% | US$73.4b | US$1,491.59 | PE31.9x | E10.1% | 2.2% | ||
EL * | US$2,375.03 | -6.4% | -46.6% | US$51.3b | US$2,665.53 | PE109.9x | E35.3% | 1.8% | ||
KMB * | US$2,057.99 | 0% | -14.1% | US$42.1b | US$2,107.44 | PE23.9x | E9.1% | 3.9% | ||
HLN N | UK£66.02 | 0% | n/a | UK£32.4b | UK£66.79 | PE30.6x | E14.9% | 0.7% | ||
KVUE * | US$375.00 | 0% | n/a | US$39.4b | US$414.84 | PE23.7x | E8.7% | 3.9% | ||
RB N | UK£1,090.86 | 0% | n/a | UK£31.2b | UK£1,441.41 | PE19.1x | E12.4% | 4.4% | ||
HLN1 N | UK£141.12 | 0% | -6.1% | UK£30.0b | UK£155.11 | PE28.6x | E11.6% | 1.8% | ||
BEI N | €2,544.73 | 0% | n/a | €30.2b | €2,662.14 | PE41x | E13.3% | 0.8% | ||
CHD * | US$1,858.90 | 9.7% | 17.0% | US$25.5b | US$1,799.72 | PE33.8x | E6.6% | 1.1% | ||
8113 N | JP¥731.12 | 0% | n/a | JP¥3.3t | JP¥742.19 | PE48.9x | E10.7% | 0.7% | ||
CLX * | US$2,620.80 | 0% | -9.6% | US$18.7b | US$2,701.09 | PE233.9x | E33.5% | 3.2% | ||
ESSITYB N | kr512.89 | 0% | -5.4% | kr201.6b | kr571.44 | PE25.4x | E15.8% | 2.5% | ||
KIMBER A | Mex$37.75 | -0.5% | -0.1% | Mex$112.3b | Mex$44.13 | PE16.6x | E8.3% | 4.3% | ||
KIMBER B | Mex$35.16 | 0% | 0% | Mex$111.9b | Mex$41.14 | PE17.5x | E10.7% | 4.4% | ||
4527 N | JP¥346.35 | 0% | n/a | JP¥638.8b | JP¥434.80 | PE24.9x | E9.7% | 0.8% | ||
SPB * | US$1,845.00 | 0% | 0% | US$3.1b | US$2,185.52 | PS1x | E63.8% | 2.3% | ||
NTCO N | R$89.82 | 0% | n/a | R$14.8b | R$137.46 | PB0.7x | E105.0% | 1.2% | ||
ICOS N | €216.12 | 0% | n/a | €1.6b | €210.23 | PE35.7x | E16.4% | 1.0% | ||
ONTEX N | €170.56 | 0% | 0% | €579.3m | €227.61 | PB0.7x | E103.4% | 0% | ||
MED * | US$507.81 | -26.9% | n/a | US$374.1m | US$548.79 | PE3.8x | E-63.2% | 0% |